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ABSTRACT 
 
The aim of this study was to examine the effects of post-activation potentiation 
(PAP) on performance and physiological measures during endurance cycling. 
Eleven well trained male endurance cyclists (mean ± SD; 32.7 ± 10.3 yr; 70.7 ± 
7.2 kg; VO2max 65.3 ± 5.3 ml·kg-1·min-1) performed two 4 km cycling time trials 
on separate days following 5 minutes recovery after a) a moderate intensity 
cycling warm-up at 60% of VO2peak for 6.5 minutes (CONTCOND), and b) a 
PAP-inducing cycling warm-up (PAPCOND) consisting of 5 minutes at 60% of 
VO2peak then 3 x 10 s at 70% of peak power interspersed with 30 s recovery, in 
a counterbalanced design. Before the start of the time trial blood lactate was 
significantly elevated following PAP-inducement compared to the moderate 
warm-up (4.88 ± 1.36 mM·L-1 vs 1.14m ± 0.26 mM·L-1).  A non-significant 
possibly small improvement in completion time (1.7 ± 3.5 s, P = 0.17) and a 
non-significant increase in power (5.1 ± 10.5 W, P = 0.16) were attributed to 
PAPCOND. Following PAPCOND oxygen uptake (VO2) was elevated by 1.44 ± 
1.65 ml·kg-1·min-1 (P = 0.02) and respiratory exchange ratio (RER) was 
decreased by 0.05 ± 0.02 (P < 0.01) compared to CONTCOND. All differences 
were greatest in the first 1500 m. A PAP-inducing warm-up leads to small 
performance improvements in endurance cycling that are associated with 
elevated blood lactate and increased VO2. These performance improvements 
are most evident in the early stages so would be of greatest benefit in short 
endurance cycle races. 
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1. INTRODUCTION 
 
Before athletic events most competitors will perform some kind of warm-up 
activities in the expectation that they will enhance their performance (Bishop, 
2003b). Indeed the review by Fradkin, Zazryn and Smoliga, (2010) 
demonstrates that many studies have found warm-ups have a beneficial effect, 
although the mechanisms by which they work differ due to the type, intensity 
and duration of the warm-up. These mechanisms include increasing muscle 
temperature (Shellock & Prentice, 1985), the speeding up of oxygen uptake 
(VO2) kinetics (Burnley, Doust, & Jones, 2005) and improving efficiency by 
reducing the oxygen cost of performance (Barnes, Hopkins, McGuigan, & 
Kilding, 2015). Warm-ups also risk negatively affecting performance should they 
induce fatigue by being too intense (Sargeant & Dolan, 1987), having 
insufficient recovery before the event (Needham, Morse, & Degens, 2009), or 
elevating body temperature (Bishop & Maxwell, 2009). 
 
A number of different types and strategies of warm-up exist to elicit the above 
responses including active warm-up, passive warm-up, and stretching (Bishop, 
2003a; Kilduff, Finn, Baker, Cook, & West, 2013). One contemporary technique 
undergoing greater scrutiny in the search for performance gain is Post-
activation potentiation (PAP). PAP is a phenomenon where the performance of 
a muscle is enhanced by its recent contractile history (Hodgson, Docherty, & 
Robbins, 2005) resulting in an increased rate of force development (RFD) in its 
fibres (Jubeau, Gondin, Martin, Van Hoecke, & Maffiuletti, 2010). Whilst the 
underlying mechanisms behind PAP are still to be fully determined (Robbins, 
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2005), there are two different mechanisms often suggested as the explanation 
for the phenomenon; the phosphorylation of myosin regulatory light chains 
(RLC) (Levine, Kensler, Yang, Stull, & Sweeney) and neural factors enhancing 
motor unit recruitment (Anthi, Dimitrios, & Christos, 2014). Phosphorylation of 
myosin RLC results in the actin-myosin interaction becoming more sensitive to 
calcium ions released from the sarcoplasmic reticulum (Sale, 2002). This is 
thought to increase the rate of the cross bridging action, effectively increasing 
the RFD (Hodgson et al., 2005), whereas increased neural excitability leads to a 
greater number of motor units being recruited consequently increasing in the 
number of higher order motor units recruited and resulting in an increased RFD 
(Anthi et al., 2014). 
 
Whether the underlying mechanism behind PAP is phosphorylation of myosin 
RLC, enhanced neural excitability or a combination of factors, the effect of PAP 
does not extend to increasing maximal force due to the saturated concentration 
of calcium found in the presence of high frequency tetanic contractions (Sale 
2002). Conversely low frequency tetanic contractions, typical of sustained 
submaximal contractions have been found to produce an increased RFD 
(Vandenboom, Grange, & Houston, 1993). PAP has also been shown to be 
more pronounced in type II muscle fibres (Hamada, Sale, MacDougall, & 
Tarnopolsky, 2003) due to their higher levels of myosin light chain kinase 
(Ryder, Lau, Kamm, & Stull, 2007) and their greater activation according to 
Henneman’s size principle (Henneman, Somjen, & Carpenter, 1965). These 
combined characteristics have led to a number of PAP studies being carried out 
in submaximal explosive sports such as sprinting, jumping and throwing (Bevan, 
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Cunningham, Tooley, Owen, Cook, & Kilduff, 2010; Hirayama, 2014; Mitchell & 
Sale, 2011; Tillin & Bishop, 2009), demonstrating that PAP can enhance 
performance if the inducement loads and recovery parameters are favorable.  
Sale (2004) proposed that PAP would be beneficial to general endurance 
performance where submaximal forces are repeatedly exerted, invoking the low 
frequency tetanic contractions where calcium sensitivity is a factor in the force 
production. Although prior activation of a muscle beneficially induces PAP, there 
is also the coexisting effect of fatigue to be considered, which can produce a net 
negative effect in performance (Rassier & Macintosh, 2000). The balance of 
PAP and fatigue was evident in the study by Chiu et al. (2003), who found that 
the training status of participants influenced the overall response to PAP with 
athletes displaying enhanced performance compared to recreationally trained 
participants. Hamada, Sale, and Macdougall (2000) exploited the trained status 
of different muscle groups within their participant groups of cyclists (lower body 
trained) and triathletes (lower and upper body trained), to demonstrate how the 
training status of individual muscle groups affects their response to PAP. It was 
suggested that endurance training had enhanced fatigue resistance and the 
increased number of myosin light chains in the type I muscle fibres within the 
trained muscle groups. 
 
Whilst it can be argued that all muscle activity induces PAP to some extent 
(Sale, 2004), therefore many warm-up studies may have unwittingly incurred 
the benefits of PAP, surprisingly few studies have explicitly examined its effect 
on endurance performance. However, one recent study by Barnes et al. (2015), 
did observe increased endurance running performance using trained endurance 
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runners after a PAP inducing warm-up running strides with a weighted vest. 
Typically PAP-inducing protocols have used either ballistic exercise with 
movement at maximum velocity (Maloney, Turner, & Fletcher, 2014) or heavy 
resistance exercise (HRE), often in repeated bouts of muscle activity lasting 10 
s (Vandervoort, Quinlan, & McComas 1983). HRE protocols often use a load 
based on a high percentage of a participant’s one-repetition maximum lift (Seitz, 
de Villarreal, & Haff, 2013), interspersed with short recovery periods and a 
longer recovery period before the measurement of the key performance variable 
(Wilson et al., 2013). Barnes et al. (2015) attempted to make the PAP 
inducement sport-specific by undertaking 6 x 10 s runs in a weighted vest with 
30 s recovery in between. Another feature of the Barnes et al. (2015) study was 
that it investigated the otherwise unexamined relationship between PAP and 
VO2, albeit only measured at submaximal levels. VO2 is a performance-limiting 
component of endurance, and as such characterises many endurance 
performance based studies (Christensen & Bangsbo, 2015; Faisal, Beavers, 
Robertson, & Hughson, 2009; Jones, Wilkerson, Burnley, & Koppo, 2003) but 
as yet, owing to the lack of research, no inferences can be drawn as to the 
positive or negative effects of PAP on VO2.at perimaximal and supra-maximal 
intensities. 
 
The effects of PAP have been investigated in sprint cycling (Baker et al., 2008; 
Smith, Fry, Weiss, Li, & Kinzey, 2001; Tomaras & MacIntosh, 2011) and whilst 
the results of these studies have been equivocal, they have highlighted the 
importance of training status and the balance of PAP and fatigue in obtaining 
improvements in power output. There have also been many studies into the 
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effects of warm-up routines but not PAP per se (Burnley, Doust, Carter, & 
Jones, 2001; Hajoglou, et al., 2005; Palmer, Jones, Kennedy, & Cotter, 2009; 
Wilkerson, Koppo, Barstow, & Jones, 2004), demonstrating how certain warm-
up routines can produce power and speed improvements in endurance cycling, 
particularly in the early stages of performance. The 4 km individual track pursuit 
race is a cycling endurance event performed at supra-maximal intensity in terms 
of VO2, and yet it is estimated to rely on an 85% aerobic contribution 
(Jeukendrup, Craig, & Hawley, 2000) for its energy supply in male athletes. 
Sale (2004) advocates that PAP would be effective for endurance events and 
also suggests that PAP has a self-perpetuating effect due to the on-going 
contractile history of the muscle. For those reasons it could be argued that a 
short, intense endurance event such as a 4 km pursuit would be the ideal 
candidate for the positive effects of PAP. In particular, it seems likely that such 
a benefit would be evident in the early stages of the event prior to the self-
perpetuating component being established, and where a small performance 
gain could be a race-winning margin.  
 
A performance gain in a race such as the 4 km pursuit is measured in time, 
however speed and completion time are a function of power output (Jeukendrup 
et al., 2000), which in turn is derived from the force-angular velocity relationship 
in pedalling (Sargeant, Hoinville, & Young, 1981). The sustainable power output 
produced and the maximization of both aerobic and anaerobic energy systems 
are critical to the 4 km pursuit (Craig et al., 1993). The effects that PAP may 
have on force, power and the energy systems at supra-maximal intensities are 
currently unknown. The principal aim of this study was therefore, to compare a 
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cycle specific warm-up routine inducing PAP with a moderate intensity warm-up 
cycling at 60% of VO2peak, to determine whether there is a performance benefit 
for well-trained cyclists over a 4 km time trial. Specifically, it was hypothesised 
that the PAP warm-up would enhance force, power output and 4 km time 
compared to the alternative warm-up. In addition, the study examined the 
effects of these warm-ups on certain physiological measures that relate to 
overall performance.  
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2. METHODS 
 
Participants 
Eleven healthy males were invited to volunteer to participate in the study (mean 
± SD; age 32.7 ± 10.3 years; height 180.9 ± 7.7 cm; mass 70.7 ± 7.2 kg), that 
had prior approval by the University of Chester’s Faculty of Life Sciences ethics 
committee. The participants were well trained, competitive endurance cyclists, 
ranging from regional to international level (VO2max 65.3 ± 5.3 ml·kg-1·min-1; 
training volume 8.9 ± 2.7 hours·week-1; training experience 9.6 ± 7.5 years). All 
participants gave written informed consent prior to their participation and 
completed a health screening questionnaire before each exercise session. Prior 
to the start of each test a detailed explanation of the test was given to the 
participant, along with instruction on how to interpret and use the subjective 
rating scales for effort and pain. Everyone undertook all components of the 
study, however one participant did not complete the post-activation potentiating 
component satisfactorily and his data has been excluded from the results. 
 
Experimental Design 
In a repeated measures counter balanced design, participants visited the 
laboratory on three separate occasions over a maximum of 10 days. During the 
first visit participants undertook a graded incremental cycling test to exhaustion 
to determine power output intensities relative to VO2peak and a cycling maximum 
power test, in order to determine individual intensities for use in the 
experimental trials. After a rest period of approximately one hour, participants 
then completed a familiarisation of the experimental trial conditions. Between 2 
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and 7 days later the participants returned for their first experimental trial; 24–96 
hours after that they undertook their final and alternate experimental trial. The 
experimental trials consisted of either the control condition (CONTCOND) and a 
4 km time trial, or the PAP inducing condition (PAPCOND) and a 4 km time trial. 
Participants were asked to refrain from alcohol and caffeine on the day of any 
sessions, not to have eaten or untaken any strenuous exercise in the preceding 
24 hours. The two experimental sessions were conducted at approximately the 
same time of day under similar air-conditioned environmental conditions within 
the Department of Sports and Exercise Science laboratory at the University of 
Chester. The two ergometers used in the sessions were set up based on 
measurements the participants supplied from their own bicycles, which were 
then replicated in subsequent sessions. Participants also used their own shoes 
and preferred pedal type throughout. 
 
The key dependent variables measured during the 4 km trials were time, power 
output (PO) and force. Other physiological and perceptual markers of 
performance measured were VO2, Volume of carbon dioxide expired (VCO2), 
blood lactate, heart rate (HR), ratings of perceived exertion on a scale of 6 to 20 
(RPE; Borg, 1970) and leg pain on a 1 to 10 scale (Cook, O'Connor, Oliver, & 
Lee 1998). 
  
Procedures 
Baseline tests 
A graded incremental cycling test was performed on an electronically braked 
ergometer (Lode Excalibur Sport, Lode BV, Groningen, Netherlands). Cycling 
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commenced at 120 W at a self-selected cadence and was increased by 30 W 
every 3 minutes until volitional exhaustion. Blood lactate was measured in the 
final 30 s of each stage via a finger-tip blood sample (Lactate Pro II, Arkay, 
Kyoto, Japan), together with the participant’s RPE. Pulmonary gas exchange 
was measured breath-by-breath using an online gas analysis system (Oxycon 
Pro, Viasys Healthcare, Hochenberg, Germany), which was calibrated 
automatically prior to the test with ambient air, humidity readings and gases of 
known concentrations. VO2 was averaged over each 30 seconds and VO2peak 
was determined as the largest of the averaged values recorded. The VO2 for 
each stage was defined as the average VO2 recorded in the final minute. The 
PO relating to 60% of the VO2peak was interpolated from stages for use in the 
later experimental trials. Lactate thresholds were noted as the PO at 1 mM·L-1 
above baseline values. PO at 60% of VO2peak was checked to confirm it was 
below the lactate threshold for each participant. 
 
Following a rest of approximately 30 minutes, two maximum power cycling tests 
were performed on a Wattbike Pro cycle ergometer (Wattbike Ltd., Nottingham, 
UK). Following a brief warm-up the participants performed two 6 s sprints 
separated by approximately 5 minutes. Peak power (PP) was recorded as the 
maximum PO reached during the two attempts. A value equating to 70% of PP 
was then recorded for use in the later experimental trials. 
 
Familiarisation trial  
The familiarisation trial conducted after the baseline tests followed the same 
procedure as the PAPCOND experimental trial (described below). During the 
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familiarisation trial however, the resistance setting of the Wattbike Pro could be 
altered by the participant to a preferred setting, which was retained for both 
subsequent experimental trials. 
 
Figure 2. Schematic showing the timeline for both experimental trials. 
 
 
Experimental trials 
During each experimental trial the participant completed either the CONTCOND 
or PAPCOND on the Lode ergometer followed by a 5 minute passive recovery 
and a 4 km time trial on the Wattbike Pro. The CONTCOND consisted of a 6.5 
minute cycle at the PO calculated to elicit 60% VO2peak. The PAPCOND 
consisted of a 5 minute cycle at the same power output eliciting 60% VO2peak, 
immediately followed by 3 bouts of 10 seconds at a power equal to 70% PP, 
with 30 seconds passive recovery between bouts (see Figure 1). Participants 
were instructed to aim for a slow cadence of 60 r·min-1 for the 10 second bouts 
and their usual preferred cadence at other times. Following 5 minutes of 
passive recovery participants were instructed to perform the 4 km time trial as if 
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it were a race by completing the distance in the shortest possible time, using the 
drop handlebar position. The resistance setting selected during familiarisation 
was used throughout the 4 km trials. Participants were also requested to 
maintain the same pacing strategy for both experimental trials. All 
instantaneous details of speed, power, time and cadence were withheld from 
the participants in order to minimise self-pacing cues. Participants were verbally 
informed of their elapsed distance after each 500 metres completed. Non-
specific verbal encouragement was given throughout. Following completion of 
the trial participants were asked to remain seated passively for a further 3 
minutes. Three blood lactate measurements from finger-tip samples were taken 
at rest; 1 minute prior to the start of, and at completion of the trial. After each km 
of the 4 km trial the participant was asked to indicate their RPE and leg pain. 
HR via a chest strap (Polar Electro Oy, Kempele, Finland) and breath-by-breath 
pulmonary gas exchange were recorded throughout the 4 km trial and 3 minute 
recovery. The Wattbike Pro calculated distance and recorded time, power, 
cadence and force dynamics for each pedal revolution throughout the trials. 
Split times for each 500 metres were computed from the Wattbike Pro data 
using custom built spreadsheets in Microsoft Excel 2013 (Microsoft Corp., 
California, US) and interpolation of the elapsed times of pedal strokes. Force, 
PO, VO2, VCO2 and HR were also computed using custom spreadsheets to 
extract data for each 500m split.  
 
Statistical Analysis  
Descriptive Statistics (mean ± SD) were calculated for each dependent variable 
across each trial. The normality of distributions of the dependent variables were 
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checked using the Shapiro-Wilkes statistic. Inferential statistics were then used 
to test the main research hypotheses. Specifically paired sample t-tests were 
used to assess differences in overall completion time, PO and force variables 
due to the condition type (CONTCOND/PAPCOND). Two-way repeated 
measures analyses of variance were performed to assess the variability of the 
mean scores due to condition type (CONTCOND/PAPCOND) and distance (500 
m splits). Sphericity was checked with Mauchly’s test and accounted for where 
necessary using the Greenhouse-Geisser adjustment. Paired sample t-tests 
were used post-hoc where appropriate on pair-wise conditions. Statistical 
significance was set at P < 0.05 throughout, with Bonferroni corrections where 
appropriate. Analysis was performed using SPSS v.21 (IBM Corp., Armonk, NY, 
US).  Effect sizes and magnitude based inferences were calculated using 
spreadsheets from Hopkins (2006), and interpreted based on the completion 
times of the top 10 finishers in the November 2012 UCI omnium World Cup 4 
km time trial and the suggestions from Batterham and Hopkins (2006).  
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3. RESULTS 
 
Pre-experimental trials 
No significant differences were found in blood lactate concentrations 
(CONTCOND: 1.21 ± 0.38 mM·L-1; PAPCOND: 1.27 ± 0.46 mM·L-1, P = 0.72) 
and resting VO2 (CONTCOND: 6.37 ± 0.77 ml·kg-1·min-1; PAPCOND: 5.98 ± 
0.94 ml·kg-1·min-1, P = 0.37) before the start of the conditioning exercises. 
Blood lactate concentrations measured 60 s before the start of the 4 km 
experimental trials were significantly higher (P < 0.01) following PAPCOND 
(4.88 ± 1.36 mM·L-1) compared to CONTCOND (1.14m ± 0.26 mM·L-1).  
 
 
4 km time trial 
Completion times for the 4 km time trial were non-significantly shorter following 
PAPCOND than following CONTCOND (1.7 ± 3.5 s, P = 0.17). Similarly, mean 
PO (5.1 ± 10.5 W, P = 0.16) and mean peak force (5.7 ± 11.0 N, P = 0.13) 
differences both exhibited non-significant improvements following PAPCOND. 
Individually 7 out of 10 participants completed the 4 km trial faster after 
PAPCOND than CONTCOND, whilst 3 were slower. Probabilistic inferences 
suggest a possibly small improvement in completion times and possibly trivial 
increases in both PO and mean peak force. Gas analysis during the trials 
revealed a likely trivial and significant increase in VO2 of 1.44 ± 1.65 ml·kg-
1·min-1 (P = 0.02) due to the PAPCOND, whilst VO2peak increased in 8 out of the 
10 participants the magnitude of the non-significant increase of 0.65 ± 1.17 
ml·kg-1·min-1 (P = 0.11) was trivial. VCO2 was lower in PAPCOND than 
CONTCOND by 1.19 ± 2.51 ml·kg-1·min-1 (P = 0.17), however when divided by 
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VO2 to produce the respiratory exchange ratio (RER) which is indicative of 
metabolic effects a significant difference between the conditions appears with a 
reduced RER in the PAPCOND of 0.05 ± 0.02 (P < 0.01). Mean HR was 
significantly elevated in PAPCOND compared to CONTCOND by 4.0 ± 3.3 
b·min-1 (P < 0.01). Despite being higher before the start of the trial blood lactate 
concentrations were lower upon completion of PAPCOND than after 
CONTCOND by 0.15 ± 2.72 mM·L-1, (P = 0.12). Post exercise differences in 
VO2 during the first minute after the two trials were unclear and not significant 
(0.13 ± 1.82 ml·kg-1·min-1, P = 0.83). Differences in VO2 over the 3 minutes post 
exercise were approaching significance (0.74 ± 1.15 ml·kg-1·min-1, P = 0.07) 
and a likely small increase following PAPCOND compared with CONTCOND 
(see Table 1). 
 
Inference
Completion time (s) 315.2 ±6.7 313.5 ±6.3 -1.7 ±2.1 possibly small ↓
Power output (W) 356.8 ±21.7 361.9 ±21.6 5.1 ±6.1 possibly trivial ↑
Peak Force per pedal stroke (N) 317.6 ±28.4 323.3 ±26.0 5.7 ±6.4 possibly trivial ↑
O2 Uptake (ml·kg
-1·min-1) 57.7 ±5.3 59.1 ±5.1 1.4 ±1.0  ꝉ likely small ↑
Peak O2 (ml·kg
-1min-1) 64.5 ±5.6 65.2 ±5.4 0.7 ±0.7 possibly trivial ↑
CO2 expiration (ml·kg
-1·min-1) 66.5 ±6.3 65.3 ±5.1 -1.2 ±1.5 possibly trivial ↓
RER 1.15 ±0.54 1.11 ±0.05 -0.05 ±0.01  ꝉ most likely small ↓
Heart rate (b·min-1) 168.7 ±10.1 172.7 ±9.8 4.0 ±1.9 ꝉ very likely small ↑
Blood lactate (mM·L-1) 17.1 ±3.8 15.6 ±3.1 -1.5 ±1.6 likely small ↓
1 min post exercise VO2 (ml·kg-1·min-1) 40.8 ±3.4 40.9 ±3.1 0.1 ±1.1 unclear
3 min post exercise VO2 (ml·kg-1·min-1) 23.7 ±1.9 24.4 ±1.4 0.7 ±0.7 likely small ↑
Thresholds for the magnitude of the difference in each variable for small, moderate and large effects were determined as the 
pooled SD x 0.3, 0.9 and 1.6 respectively, with the exception of completion time.
Completion time thresholds for the magnitude of the difference for small, moderate and large effects were determined as the 
SD of the completion time of the top 10 finishers in a UCI world cup event x 0.3, 0.9 and 1.6 respectively.
CONTCOND             
(mean ± SD)
PAPCOND               
(mean ± SD)
Difference of 
means (90% 
confidence 
limits)
Thresholds for inferences: <0.5% most unlikley, 0.5%-5% very unlikely, 5%-25% unlikely, 25-75% possibly, 75%-95% likely, >95% 
most likely.
ꝉ Statistically significant difference (P  < 0.05).
 
Table 4. Differences in performance and physiological variables between 
PAPCOND and CONTCOND over the 4 km time trials. 
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Performance 
ANOVA showed a significant main effect of split number (F = 24.6, P < 0.01) 
with split times generally increasing before a slight decrease in the final split 
time due to an end spurt. There were non-significant effects due to the condition 
(F = 1.8, P = 0.21) and the interaction between condition and split number (F = 
0.5, P = 0.63). Similarly, analysis of PO revealed a significant main effect of split 
number (F = 20.2, P < 0.01) replicating the trend previously described for time, 
but not of condition (F = 2.4, P = 0.15) or interaction (F = 0.5, P = 0.62). Like 
those of PO and time, analysis of peak force also revealed a significant main 
effect of split number (F = 13.3, P < 0.01), but not of condition (F = 0.2, P = 
0.85) or interaction (F = 0.5, P = 0.62). ANOVA of pulmonary gas exchange for 
VO2 revealed that significant main effects were found on both split number (F = 
874.7, P < 0.01) and condition (F = 8.4, P = 0.02), there was also a significant 
interaction between the main effects (F = 7.9, P < 0.01). VCO2 was also 
significant over split number (F = 135.9, P < 0.01) with VCO2 rising rapidly 
before peaking mid-trial, however neither the condition main effect (F = 2.3, P = 
0.17), nor the interaction (F = 2.3, P = 0.13) were significant. RER was 
significant for both main effects of split number (F = 18.1, P < 0.01) and 
condition (F = 48.4, P < 0.01) as well as their interaction (F = 5.4, P = 0.01). 
Figure 2 depicts the significant interactions affecting VO2 and RER. HR ANOVA 
demonstrated significant main effects for split number (F = 138.4, P < 0.01) and 
condition (F = 13.3, P = 0.01) with the trend replicating that of VO2, the 
interaction between the two main effects was not significant (F = 1.7, P = 0.22). 
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Figure 2. Changes in A) oxygen uptake and B) Respiratory Exchange Ratio for 
each 500 m split of the 4 km time trials. Differences (P < 0.05) were due to the 
main effects of condition; split number, and their interactions. Plot values are 
mean ± SD. 
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Post hoc analysis examined splits 1, 2 and 3 covering the first 1500 m of the 
trials. The analysis revealed that differences in performance and physiological 
measures due to the pre-trial conditions were greatest during the early stages of 
the trial (see Table 2). 
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Inference
Split time (s) 36.31 ±2.43 36.07 ±2.64 -0.24 ±0.77 unclear
Power output (W) 451.6 ±81.5 461.5 ±91.5 9.9 ±25.0 possibly trivial ↑
Peak Force per pedal stroke (N) 363.5 ±46.2 368.5 ±51.4 5.1 ±13.1 possibly trivial ↑
O2 Uptake (ml·kg
-1·min-1) 33.0 ±3.6 36.6 ±4.4 3.5 ±1.3 ꝉ most likely small ↑
CO2 expiration (ml·kg
-1·min-1) 33.6 ±5.9 35.5 ±4.6 1.9 ±2.1 likely small ↑
RER 1.02 ±0.13 0.97 ±0.09 -0.05 ±0.04 likely small ↓
Heart rate (b·min-1) 140.1 ±13.3 145.0 ±14.4 4.9 ±2.0 ꝉ very likely small ↑
Inference
Split time (s) 38.32 ±1.75 37.77 ±1.28 -0.55 ±0.72 possibly moderate ↓
Power output (W) 385.5 ±47.4 399.3 ±39.1 13.9 ±17.4 possibly small ↑
Peak Force per pedal stroke (N) 332.7 ±36.5 335.8 ±8.5 3.0 ±11.5 unclear
O2 Uptake (ml·kg
-1·min-1) 54.0 ±6.2 57.3 ±4.6 3.3 ±1.9 ꝉ very likely small ↑
CO2 expiration (ml·kg
-1·min-1) 62.9 ±9.7 60.3 ±7.3 -2.5 ±3.7 possibly trivial ↓
RER 1.16 ±0.12 1.05 ±0.11 -0.11 ±0.04 ꝉ most likely small ↓
Heart rate (b·min-1) 162.9 ±11.4 167.1 ±11.4 4.2 ±2.3 ꝉ likely small ↑
Inference
Split time (s) 39.61 ±1.11 39.26 ±0.87 -0.35 ±0.47 possibly small ↓
Power output (W) 349.9 ±26.3 358.6 ±21.4 8.8 ±11.2 possibly small ↑
Peak Force per pedal stroke (N) 311.5 ±29.3 316.6 ±23.5 5.1 ±5.6 possibly trivial ↑
O2 Uptake (ml·kg
-1·min-1) 58.0 ±5.8 60.0 ±5.5 2.0 ±1.2 likely small ↑
CO2 expiration (ml·kg
-1·min-1) 74.2 ±9.1 71.2 ±6.6 -3.0 ±3.0 ꝉ likely small ↓
RER 1.28 ±0.12 1.19 ±0.09 -0.09 ±0.04 ꝉ most likely small ↓
Heart rate (b·min-1) 169.1 ±10.8 173.5 ±9.9 4.4 ±3.4 likely small ↑
Split time thresholds for the magnitude of the difference for small, moderate and large effects were determined as the 
SD of 1/8th of the completion time of the top 10 finishers in a UCI world cup event x 0.3, 0.9 and 1.6 respectively.
Split 1
Split 2
CONTCOND             
(mean ± SD)
PAPCOND               
(mean ± SD)
Difference of 
means (90% 
confidence 
limits)
Split 3
CONTCOND             
(mean ± SD)
PAPCOND               
(mean ± SD)
Difference of 
means (90% 
confidence 
limits)
CONTCOND             
(mean ± SD)
PAPCOND               
(mean ± SD)
Difference of 
means (90% 
confidence 
limits)
ꝉ Bonferroni corrected statistically significant difference (P  < 0.0167).
Thresholds for inferences: <0.5% most unlikley, 0.5%-5% very unlikely, 5%-25% unlikely, 25-75% possibly, 75%-95% 
likely, >95% most likely.
Thresholds for the magnitude of the difference in each variable for small, moderate and large effects were determined 
as the pooled SD x 0.3, 0.9 and 1.6 respectively, with the exception of split time.
 
 
Table 5. Differences in performance and physiological variables during splits 1 
(0 - 500 m), 2 (500 - 1000 m) and 3 (1000 - 1500 m) between CONTCOND and 
PAPCOND. 
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Subjective perceptions of effort 
Two way ANOVA results (condition x km completed) suggest no significant 
differences due to condition for RPE (F = 3.7, P = 0.86) and leg pain (F = 0.4, P 
= 0.55), but that the main effect of distance completed was significant for both 
measures; F = 137.0, (P < 0.01) and (F = 22.2, P < 0.01) for RPE and leg pain 
respectively. Both RPE and leg pain increased steadily from the start to the end 
of each trial (see Table 3). No significant interactions were found for either RPE 
(F = 1.8, P = 0.19) or leg pain (F = 0.2, P = 0.76). 
 
Inference
km 1 15.2 ± 1.3 15.5 ± 1.2 0.3 ± 0.7 unclear
km 2 16.4 ± 1.6 17.4 ± 0.5 1.0 ± 0.8 likely small ↑
km 3 17.9 ± 1.3 18.5 ± 0.7 0.6 ± 0.7 likely small ↑
km 4 19.5 ± 0.7 19.7 ± 0.5 0.2 ± 0.2 possibly small ↑
Inference
km 1 5.5 ± 0.8 5.8 ± 0.9 0.3 ± 0.7 unclear
km 2 6.3 ± 0.7 6.4 ± 1.1 0.1 ± 0.4 unclear
km 3 7.1 ± 1.2 7.1 ± 1.2 0.1 ± 0.4 unclear
km 4 7.8 ± 1.5 7.9 ± 1.3 0.1 ± 0.4 unclear
CONTCOND             
(mean ± SD)
PAPCOND               
(mean ± SD)
Difference of means 
(90% confidence 
limits)
RPE
Leg Pain
CONTCOND             
(mean ± SD)
PAPCOND               
(mean ± SD)
Difference of means 
(90% confidence 
limits)
Thresholds for inferences: <0.5% most unlikley, 0.5%-5% very unlikely, 5%-25% unlikely, 25-75% 
possibly, 75%-95% likely, >95% most likely.
Thresholds for the magnitude of the difference in each variable for small, moderate and large 
effects were determined as the pooled SD x 0.3, 0.9 and 1.6 respectively.
No statistically significant differences (P  < 0.05).
 
Table 6.Differences between CONTCOND and PAPCOND in subjective 
perceptions of RPE and leg pain after each km. 
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4. DISCUSSION 
 
The main finding from this study was that a PAP-inducing warm-up produced 
non-significant performance improvements in terms of time and power output 
over the 4 km time trials of 1.7 s and 5.1 W respectively, when compared to a 
moderate intensity warm-up. As was hypothesised the performance 
improvements were mainly realised during the initial 1500 m of the time trial and 
accounted for a disproportionate 1.1 s of the small overall improvement. Whilst 
the improvements in finish and split times were related to the increases in PO, it 
is unclear if the peak forces applied to the pedals during each pedal stroke were 
responsible per se, or whether the increased forces necessary to generate the 
additional power were distributed through the pedal stroke. These findings are 
consistent with those of Barnes et al. (2015), in that prior exercise inducing PAP 
leads to an improvement in endurance performance in trained athletes, albeit 
with a smaller magnitude of improvement than the earlier study. Whilst Barnes 
et al. (2015) observed an improvement at the end of an incremental speed test, 
the present study revealed performance improvements were predominant in the 
early stages of the experimental trial. This supports the proposition by Sale 
(2004) that any muscle activity will induce PAP, and that once initiated in an 
endurance event the effects of PAP would be ongoing due to the exercise itself. 
Consequently the benefits of PAP inducement prior to the start of exercise 
would be most evident in the early stages of an event, as per the present study. 
 
The performance changes in the present study were accompanied by 
associated changes in the physiological measures of VO2, HR, and RER, along 
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with a significant increase in blood lactate concentration following the PAP-
inducing warm-up. A moderate elevation of blood lactate has been linked with 
an improvement in subsequent endurance performance (Burnley et al., 2005; 
Jones, et al., 2003; Palmer et al., 2009; Wilkerson et al., 2004), possibly due to 
an associated increase in intra-muscular acidosis protecting against fatigue 
(Jones et al., 2003). The present study supports these associations as blood 
lactate concentration was initially higher due to PAPCOND, before increasing to 
similar levels during both trials. It can therefore be assumed that the difference 
in muscle lactate concentration between the trials would have been greatest in 
the early stages of the exercise, and that this difference coincided with the 
stages exhibiting the greatest differences in performance.  
 
In the present study increased blood lactate concentration after the PAP 
inducement corresponded with increased VO2 and HR in the first 1500 m of the 
time trial, reflecting the associations found by Palmer et al. (2009) following self-
paced and high intensity warm-ups. The increase in VO2 seen during the early 
stages of the present study following the PAP-inducing warm-up is similar to the 
findings in many studies exhibiting improved performance following effective 
prior exercise (Burnley et al., 2001; Christensen & Bangsbo, 2015; Faisal, et al., 
2009; Hajoglou et al., 2005; Palmer et al., 2009), so would appear to be a highly 
desirable effect from the PAP-inducing warm-up. Indeed moderate intensity 
warm-ups have been found to not cause an increase in VO2 contribution, or 
improve performance when compared to no warm-up conditions (Jones et al., 
2003). However, Hajoglou et al. (2005) used a different protocol for a moderate 
warm-up that did improve performance, although this protocol also increased 
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VO2 during the early stages despite it being labelled as easy. The increased 
oxidative contribution observed during the first 1500 m should lead to either i) 
an increase in PO, or ii) a reduction in oxygen debt and the sparing of anaerobic 
contribution as seen by Rossiter et al. (2001). In this study accompanying the 
elevated VO2 following PAPCOND was a reduced VCO2, a significant reduction 
in RER and a non-significant increase in PO, indicating a combination of the two 
effects was evident during the initial stages. VO2 remained slightly higher for the 
remainder of the PAPCOND trail in comparison to CONTCOND, indeed 8 out of 
the 10 participants reached a greater VO2peak in the former. The relationship 
between VO2 and PAP has only been examined by Barnes et al. (2015) who 
found a lower oxygen cost following PAP-inducement due to improved 
efficiency in sub-maximal running, conversely this study resulted in a higher 
VO2 as described above. This discrepancy is likely to be down to the 
differences in intensity where VO2 was measured, with the supra-maximal 
exercise in this study eliciting a VO2peak at or very close to the individuals 
VO2max. The additional oxygen cost aligns with both the increased calcium 
sensitivity and increased neural excitability mechanisms purported as the 
reasons behind PAP (Anthi et al., 2014; Hodgson et al., 2014; Sale, 2002), as 
both mechanisms would increase muscle activity in order to increase the RFD, 
resulting in an increased energy cost. Indeed a PAP-inducing activity adhering 
to the Henneman size principal (Henneman, 1965) of motor unit recruitment 
would result in a greater energy demand. 
 
Given the increased oxidative metabolism and the apparent sparing of 
anaerobic resources it is somewhat surprising that a significant difference in 
23 
 
end spurt was not evident. Quantifying the anaerobic contribution cannot be 
done by measurement and calculations of the anaerobic contribution in supra-
maximal exercise contains major sources of error (Palmer et al., 2009), hence 
the inferences into anaerobic contribution in this study are drawn from 
pulmonary gas exchanges and RER previously mentioned. It is possible that 
pacing cues and effort perception prevented any end spurt in either trial until the 
final seconds regardless of remaining anaerobic capacity. Pacing strategies 
were self-selected yet remained consistent for each individual between the two 
trials (see appendix 2). Adherence to a preferred strategy along with an RPE 
that increased throughout each trial may have restricted the end spurt more so 
than the availability of anaerobic resources. Instantaneous performance 
measures were withheld from the participants, however the sound from the 
airbrake of the Wattbike offered continuous feedback of any change of cadence 
or power. This feedback could also have influenced pacing and consequently 
the anaerobic contribution, particularly in the latter stages of the trial as the 
participant’s focus may have been on maintaining cadence rather than 
increasing it. 
 
Another factor which may have limited the effect of the PAP-inducement in this 
study was the optimisation of the PAP effect. Whilst training status (Hamada et 
al., 2000) and muscle fibre type (Hamada et al., 2003; Ryder et al., 2007) have 
been shown to influence the balance of PAP and fatigue (Chiu et al., 2003; 
Rassier & Macintosh, 2000), there is no precise method of optimising the 
parameters of PAP-inducement and recovery for individuals. Whilst the review 
by Wilson et al., (2013) offered guidelines which were applied to this study, the 
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guidelines were generated based mainly on studies reporting the success or 
failure to produce positive results due to PAP, rather than trials seeking an 
optimisation protocol. Despite the participants of the present study being of 
similar fitness, training background, and standard, the effectiveness of the PAP-
inducements appeared to be individualistic. This may have been due to the 
magnitude of the positive PAP effect or the net balance for each individual. The 
magnitude of the PAP effect was not measured in this study and whilst doing so 
in future studies could help maximise the positive effects of PAP, it will not aid 
the optimisation of the PAP-fatigue balance. 
 
The overall effect of this PAP-inducing pre-trial condition is similar to the effects 
found in other warm-up routines that have led to increased performance such 
as high intensity warm ups or repeated sprints (Burnley et al., 2005; Hajoglou et 
al., 2005; Jones et al., 2003; Palmer et al., 2009). In these studies elevated 
blood lactate concentrations were observed following the warm-ups, and 
elevated VO2 and increased PO was observed in the early stages of the trials. 
Whether PAP is simply inducing the same effects as these types of warm-up or 
if can be used complimentary to existing routines in order to increase the 
benefits is a matter for future research. Investigations into complex warm-up 
routines incorporating PAP should also look at the individual responses to the 
PAP-fatigue balance and recovery times. 
 
Conclusions 
This is the first study to look specifically at PAP as a warm-up for an endurance 
cycling time trial, and the first to examine the effects of a PAP warm-up on 
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pulmonary gas exchange in a supra-maximal condition. The small improvement 
in completion time of 1.7 s and increase in power of 5.1 W whilst not significant 
could easily be a race winning improvement in a world where ever smaller 
margins make a difference. The effects of the PAP-inducement would appear to 
benefit the first 1500 m or 2 minutes of exercise before the on-going effort 
produces a PAP effect itself. The beneficial effects of PAP would appear to be 
linked to a pre-trial increase in lactate concentrations and subsequent elevation 
of VO2 in the early stages of the event. 
 
Practical implications 
This study specifically attempted to exploit the effects of PAP in a cycle-specific 
manner for a cycling event. The effects would be most beneficial in the short 
endurance racing typically encountered in track racing, such as the individual 
pursuit, team pursuit or the kilo. Although this study used cycle ergometers to 
exercise a degree of control over the PAP-inducement in the laboratory, the 
essence of high power, slow cadence cycling in 10 s efforts could be 
reproduced with high resistance and high gearing on a turbo trainer and geared 
road bike, equipment which is already commonly used prior to track racing. 
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Appendix 1.  – Additional Methodology 
 
Data extraction for 500 m splits 
 
Wattbike time, power & peak force analysis was achieved by connected a PC to 
the Wattbike head unit and importing the ride file into Wattbike Expert software 
following each 4km time trial. Within the Wattbike Expert application the “start 
analyse with first sample” was set on, then export analysis modules option was 
run to export the relevant data to a text file. Seven modules were selected for 
the export (Elapsed Time, Distance Total, Heart Rate, Force Peak, Avr 
Pace/1000m, Power Avr Power). The exported text file was then imported into a 
custom built excel spreadsheet in the Wattbike tab starting at cell A1. The 
completion time read from the Wattbike head unit was manually entered into 
cell N21. The spreadsheet automatically extracted the split times for each 500 
m using interpolation of the distance total column. Using the cell references 
determined for each 500 m split the spreadsheet calculated the mean power 
and mean peak force for each split from the imported data. The cumulative 
times, split time, mean power and mean peak force for each split are displayed 
for each split in the array R20..Z28, with totals for the ride displayed in 
S30..Z31. 
 
Gas Analysis data was exported as a text file for each 4 km time trial using the 
breath by breath export option from the Viasys software. The export included 
the covered the duration of the 4 km trial and a minimum of 3 minutes of post 
exercise gas exchange data. The text file was then imported into a custom built 
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excel spreadsheet on the gas tab page starting in cell A1. The imported file was 
manually checked for missing data in columns C, G & I (heart rate, VO2 & 
VCO2 respectively), if any missing data was encountered it was be rectified by 
interpolating using the values immediately above and below. The spreadsheet 
included calculations to give weighting to the analysis of each breath based on 
the time interval between breaths (Columns K…P). Using split and completion 
times from the Wattbike tab the spreadsheet used the weighted values to 
calculate means of Heart rate, VO2 & VCO2 foe each split. For the start and end 
of each split the calculations used the proportional values between breaths 
based on where the split time occurred between breaths. 500 m split 
parameters were produced in the range X3..Z11 for Heart rate, VO2 & VCO2. 
Post exercise VO2 consumption and VCO2 expiration was calculated for each 
of 3 minutes following the completion time taken from the Wattbike tab, using 
the weighted values. Values per minute, means, and totals are found in cells 
X16..AB20. 
 
All split analysis files containing the imported raw data and calculated outputs 
for both the CONTCOND and PAPCOND trials by each participant are 
contained in the data disk. 
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Appendix 2.  – Additional Results 
 
See data disk for all raw data, 500 m split data extracts and statistical results 
and MBI calculations. 
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Appendix 3.  – Materials 
Ethics approval form 
 
 
 
 
 
 
 
 
 
  
Faculty of Life Sciences 
Research Ethics Committee 
 
frec@chester.ac.uk 
05/05/2015 
 
Alan Chorley 
45 Westcliff Gardens 
Appleton 
 
 
Dear Alan 
 
Study title: A study to determine the performance effects of post-activation 
potentiation in a 4km endurance cycling time trial in trained 
endurance cyclists.  
FREC reference: 1028/15/AC/SES 
Version number: 1  
 
Thank you for sending your application to the Faculty of Life Sciences Research Ethics 
Committee for review. 
 
I am pleased to confirm ethical approval for the above research, provided that you comply 
with the conditions set out in the attached document, and adhere to the processes described 
in your application form and supporting documentation.  
 
The final list of documents reviewed and approved by the Committee is as follows: 
 
Document                       Version Date 
Application Form                                   1 March 2015 
Appendix 1 – List of References 1 March 2015 
Appendix 2 – Summary CV for Lead Researcher 1 March 2015 
Appendix 4 – Participant Information Sheet [PIS] 2 April 2015 
Appendix 5 – Participant Consent Form 2 April 2015 
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Appendix 6 – Risk Assessment  1 March 2015 
Appendix 3 – Additional researcher CV 1 March 2015 
Appendix 7 – Pre-test questionnaire* 2 April 2015 
Appendix 8 -  Data Collection Procedures  1 April 2015 
Response to FREC request for further information or clarification  April 2015 
*Delete Q7 as all participants are male. 
 
Please note that this approval is given in accordance with the requirements of English law only. 
For research taking place wholly or partly within other jurisdictions (including Wales, Scotland 
and Northern Ireland), you should seek further advice from the Committee Chair / Secretary or 
the Research and Knowledge Transfer Office and may need additional approval from the 
appropriate agencies in the country (or countries) in which the research will take place. 
 
With the Committee’s best wishes for the success of this project.  
 
Yours sincerely, 
 
 
 
 
 
Dr. Stephen Fallows 
Chair, Faculty Research Ethics Committee 
 
Enclosures: Standard conditions of approval.   
 
Cc. Supervisor/FREC Representative 
 
 
40 
 
Participant information form 
 
 
 
 
 
 
 
Participant information sheet 
 
Can Post Activation Potentiation during a warm-up lead to a performance 
improvement in endurance cycling? 
 
 
You are being invited to take part in a research study.  Before you decide, it is important for you 
to understand why the research is being done and what it will involve.  Please take time to read 
the following information carefully and discuss it with others if you wish.  Ask us if there is 
anything that is not clear or if you would like more information.  Take time to decide whether or 
not you wish to take part.  
 
Thank you for reading this. 
 
What is the purpose of the study? 
This purpose of this research is to investigate whether Post Activation Potentiation, or PAP as it 
is often known, can lead to a performance improvement in an endurance cycling event. PAP is 
the phenomenon whereby the performance of a muscle is enhanced by its recent activity.  
 
This study will examine the effects of PAP on trained endurance cyclists as part of a pre-race 
strategy, by including short duration heavy resistance cycling at the end of a warm up, prior to a 
4 km time trial, compared to the same warm-up that does not include PAP inducement. The aim 
is to detect any performance advantage due to PAP and to explain where that advantage 
comes from. 
 
Why have I been chosen? 
The study requires trained endurance cyclists. This is because it is hypothesized that the 
relevant muscles will have certain characteristics such as fatigue resistance and speed on 
contraction that could benefit from the PAP conditioning. 
 
You have been chosen as it is expected that you would meet the selection criteria of being male 
aged 20-45 years, an experienced cyclist (who has trained for at least 5 years, or competed for 
at least 2 years) who currently trains ≥ 3 times per week for ≥ 180 minutes per week, and have 
a VO2max ≥ 55 ml/kg/min. 
 
Do I have to take part? 
It is up to you to decide whether or not to take part.  If you decide to take part you will be given 
this information sheet to keep and be asked to sign a consent form.  If you decide to take part 
you are still free to withdraw at any time and without giving a reason.  A decision to withdraw at 
any time, or a decision not to take part, will not affect you in any way. 
 
 
What will happen to me if I take part? 
You will be asked to attend the University’s Human Performance Laboratory for 4 sessions. 
These will consist of a baseline testing session, a habituation session, and two experimental 
sessions, within a period of 4-11 days. The baseline and habituation sessions can be combined 
into a single visit if desired. 
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The baseline testing session will involve certain physiological tests to determine parameters for 
the later tests, including maximum aerobic and anaerobic efforts. The other 3 sessions will 
include easy warm-ups, the 3 x 10 seconds heavy resistance PAP conditioning, and a 4km time 
trial, all on static bikes. 
 
Lab sessions are likely to last up to 2 hours for the baseline testing, and up to 1 hour for the 
others. 
 
What are the possible disadvantages and risks of taking part? 
The sessions will include tests to exhaustion. Expired air will be monitored by the wearing of a 
face mask covering the mouth and nose. Lactate testing will involve testing a small drop of 
blood after a fingertip pin prick. Any or all of these may be considered a discomfort, however 
there will be no lasting effects from any of the tests or sessions.  
 
You will also be asked to adhere to certain requests about alcohol and caffeine consumption, 
meals and exercise prior to the sessions. 
 
 
What are the possible benefits of taking part? 
As an experienced cyclist you may be interested in learning about your own physiological make-
up. The testing will include determining your individual values of VO2max and lactate thresholds, 
together with their corresponding heart rate and power values. These values are often used by 
cyclists in their own training regimes. Depending upon the study’s findings and your own 
response to the PAP, you may also be able to improve your own pre-race strategy. You will of 
course be contributing to the wider development of knowledge, specifically if, how and why PAP 
can be advantageous to cycling. 
 
 
What if something goes wrong? 
If you wish to complain or have any concerns about any aspect of the way you have been 
approached or treated during the course of this study, please contact Professor Sarah Andrew, 
Dean of the Faculty of Life Sciences, University of Chester, Parkgate Road, Chester, CH1 4BJ, 
01244  513055. 
 
 
Will my taking part in the study be kept confidential? 
All information which is collected about you during the course of the research will be kept strictly 
confidential so that only the researcher carrying out the research will have access to such 
information.   
 
 
What will happen to the results of the research study? 
The results will be written up into a dissertation for my final project of my MSc. Individuals who 
participate will not be identified in any subsequent report or publication. 
 
Who is organising the research? 
The research is conducted as part of a MSc in Sport & Exercise Sciences within the Department 
of Sport and Exercise Sciences at the University of Chester. The study is organised with 
supervision from the department, by Alan Chorley, an MSc student. 
 
Who may I contact for further information? 
If you would like more information about the research before you decide whether or not you 
would be willing to take part, please contact: 
 
Alan Chorley. 1428583@chester.ac.uk. 
 
Thank you for your interest in this research. 
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Informed consent form 
 
 
 
 
 
 
 
 
Title of Project: A study to determine the performance effects of post-activation 
potentiation in a 4 km endurance cyclng time trial in trained endurance cyclists 
 
Name of Researcher:  Alan Chorley 
 
 
 
 
       Please initial box 
 
1. I confirm that I have read and understand the information sheet  
     for the above study and have had the opportunity to ask questions. 
 
2. I understand that my participation is voluntary and that I am free to  
     withdraw at any time, without giving any reason and without my  
     legal rights being affected. 
 
3. I agree to take part in the above study.    
 
 
 
 
 
 
___________________                _________________   _____________ 
Name of Participant Date  Signature 
 
 
 
 
 
 
Researcher Date Signature 
 
 
 
 
 
1 for participant; 1 for researcher 
43 
 
Health questionnaire 
 
 
 
 
 
Pre-test Questionnaire 
 
A study to determine the performance effects of post-activation 
potentiation in a 4 km endurance cyclng time trial in trained endurance 
cyclists 
 
Researcher: Alan Chorley 
 
Name:_________________________________  Test date:________________ 
 
 
Contact number:____________________________ Date of birth:___________ 
 
In order to ensure that this study is as safe and accurate as possible, it is important that 
each potential participant is screened for any factors that may influence the study.  
Please circle your answer to the following questions: 
 
1. Has your doctor ever said that you have a heart condition and that     
you should only perform physical activity recommended by a doctor? 
 
2. Do you feel pain in the chest when you perform physical activity? 
 
3. In the past month, have you had chest pain when you were not 
performing physical activity? 
 
4. Do you lose your balance because of dizziness or do you ever lose 
consciousness? 
 
5. Do you have bone or joint problems (e.g. back, knee or hip) that 
could be made worse by a change in your physical activity? 
 
6. Is your doctor currently prescribing drugs for your blood pressure or 
heart condition? 
 
7. n/a 
 
8. Have you injured your hip, knee or ankle joint in the last six 
months? 
 
9. Do you know of any other reason why you should not participate in 
physical activity? 
 
Thank you for taking your time to fill in this form. If you have answered ‘yes’ to any of 
the above questions, unfortunately you will not be able to participate in this study. 
YES/NO 
YES/NO 
YES/NO 
YES/NO 
YES/NO 
YES/NO 
n/a 
YES/NO 
YES/NO 
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Bike fit collection form 
 
 
 
 
 
 
 
 
Title of Project: A study to determine the performance effects of post-activation 
potentiation in a 4 km endurance cyclng time trial in trained endurance cyclists 
 
Name of Researcher:  Alan Chorley 
 
 
 
Bike Setup & configuration 
 
 
 
 
Which pedal type do you use? ____________________________________ 
 
What Crank Length do you normally ride? ___________________________ 
 
Do you wish to use your own saddle (if so please state model) ___________ 
 
_____________________________________________________________ 
 
 
 
 
Please note the following measurements with reference to the attached bike-fit 
diagram. 
 
Measurement 
 
A -Centre of bottom bracket to top of saddle (taken in line through the seat post) __________ 
 
B –Horizontal distance from the tip of the saddle to the centre of bottom bracket __________ 
 
C –Tip of saddle to centre of handlebars (via the shortest direct line) ___________________ 
 
D –Vertical distance from centre of bottom bracket to centre of handlebars ______________ 
 
 
 
 
* Please bring pedals, shoes with appropriate cleats and saddle (if required) to all 
sessions unless informed otherwise.  
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Bike fit diagram 
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Laboratory testing schedule 
 
June 
Fri 19th (6pm) - Partipant#1 -baseline 
Fri 26th (1pm) - Partipant#1 -trial1  
Fri 29th (4pm) - Partipant#1 -trial2 
 
July 
Fri 3rd (3pm) - Partipant#2 -baseline 
Sat 4th (11am) - Partipant#3 -baseline 
Mon 6th (7pm) - Partipant#3 -#1 \Partipant#2 trial1 
Thu 9th (7pm) - Partipant#3 -#2 \Partipant#2 trial2 
Tue 14th (10am) -Partipant#4 -baseline 
Thu 16th (5.30pm) - Partipant#4 - trial1 
Fri 17th (2pm) - Partipant#5 –baseline \ Partipant#4 - trial2 
Mon 20th (9.30am) - Partipant#6 baseline \ Partipant#5 -trial1 
Wed 22nd (9.30am) - Partipant#5 -trial2 \ Partipant#6 trial1 
Thus 23rd (9.30am) - Partipant#6 trial2 
Tue 28th (4pm) - Partipant#7 – baseline \ Partipant#8 - baseline 
Fri 31st (5pm) - Partipant#8 - trial1 
 
August 
Sat 1st (3pm) - Partipant#8 - trial2 \ Partipant#9 - baseline 
Mon 3rd (4pm) - Partipant#7 - trial1 \ Partipant#9 - trial1 
Tue 4th (4pm) - Partipant#7 - trial2 \ Partipant#9 - trial2 
Mon 10th (10am) - Partipant#10 - baseline 
Mon 17th (10am) - Partipant#11 - baseline 
Tue 18th (10am) - Partipant#10 - trial1 
Wed 19th (10am) - Partipant#10 - trial2 \ Partipant#11 - trial1 
Thu 20th (10am) - Partipant#11 - trial2 
 
Trials days apart: 
(#1)-3, (#2)-3, (#3)-3, (#4)-1, (#5)-2, (#6)-1, (#7)-1, (#8)-1, (#9)-1, (#10)-1 
 
